394
Views
7
CrossRef citations to date
0
Altmetric
Review Articles

Therapeutic effects of icariin and icariside II on diabetes mellitus and its complications

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Le Gong, Rui Wang, Xinyu Wang, Jing Liu, Zhaodi Han, Qian Li, Yi Jin & Hui Liao. (2023) Research progress of natural active compounds on improving podocyte function to reduce proteinuria in diabetic kidney disease. Renal Failure 45:2.
Read now

Articles from other publishers (6)

Sheng Zheng, Guan-Yu Hu, Jun-Hua Li, Jia Zheng & Yi-Kai Li. (2024) Icariin accelerates bone regeneration by inducing osteogenesis-angiogenesis coupling in rats with type 1 diabetes mellitus. World Journal of Diabetes 15:4, pages 769-782.
Crossref
Kaixi Ding, Wei Jiang, Juejue Zhangwang, Yu Wang, Jing Zhang & Ming Lei. (2023) The potential of traditional herbal active ingredients in the treatment of sarcopenia animal models: focus on therapeutic effects and mechanisms. Naunyn-Schmiedeberg's Archives of Pharmacology 396:12, pages 3483-3501.
Crossref
Kenneth Maiese. (2023) The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk. Frontiers in Immunology 14.
Crossref
Xiaoling Zhang, Bingling Tang, Sijie Wen, Yitong Wang, Chengxue Pan, Lingbo Qu, Yulong Yin & Yongjun Wei. (2023) Advancements in the Biotransformation and Biosynthesis of the Primary Active Flavonoids Derived from Epimedium. Molecules 28:20, pages 7173.
Crossref
Kenneth Maiese. (2023) The Metabolic Basis for Nervous System Dysfunction in Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease. Current Neurovascular Research 20:3, pages 314-333.
Crossref
Kenneth Maiese. (2023) Cognitive Impairment in Multiple Sclerosis. Bioengineering 10:7, pages 871.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.